WHO WE ARE / Investment Professionals
Alex de Winter
Alex de Winter has a background in bioscience and technology development. A Partner, he evaluates investments in the areas of life sciences and personalized medicine. He joined Mohr Davidow in 2009 after working at two life science start-ups. He knows well the "work-all-night and sleep-under-the-bench" lifestyle that is part of getting a company off the ground.
"We share our entrepreneurs' passion for revolutionizing health care, and partner with them to make companies successful."
Prior to Mohr Davidow, Alex was an early employee at Pacific Biosciences in Menlo Park, where he researched single-molecule DNA sequencing, integrating biochemistry, optics, and nanotechnology.
Alex previously worked at 454 Life Sciences (acquired by Roche), where he advanced the biochemistry behind the company's GS20, the first of the next-generation DNA sequencers.
Contact
Alex de Winter
Facts & Statistics
- Graduated magna cum laude from Amherst College. Alex also earned a doctorate in Chemistry from Stanford University, and received an MBA with honors from UC Berkeley.
- Alex is the author or co-author of ten scientific publications on topics ranging from gas-phase spectroscopy to photosynthesis to DNA sequencing, and two patent applications.
